| Product Code: ETC8274493 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Candida Auris Infection Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Candida Auris Infection Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Candida Auris Infection Market - Industry Life Cycle |
3.4 Mexico Candida Auris Infection Market - Porter's Five Forces |
3.5 Mexico Candida Auris Infection Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Mexico Candida Auris Infection Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.7 Mexico Candida Auris Infection Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Mexico Candida Auris Infection Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Mexico Candida Auris Infection Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Candida Auris Infection Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Candida auris infections in Mexico |
4.2.2 Growing awareness and focus on healthcare-associated infections |
4.2.3 Rising investments in healthcare infrastructure and infection control measures |
4.3 Market Restraints |
4.3.1 Limited availability of effective antifungal medications |
4.3.2 Challenges in early detection and diagnosis of Candida auris infections |
4.3.3 Lack of standardized treatment guidelines for Candida auris infections |
5 Mexico Candida Auris Infection Market Trends |
6 Mexico Candida Auris Infection Market, By Types |
6.1 Mexico Candida Auris Infection Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Mexico Candida Auris Infection Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Mexico Candida Auris Infection Market Revenues & Volume, By Antifungal Drugs, 2021- 2031F |
6.1.4 Mexico Candida Auris Infection Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.5 Mexico Candida Auris Infection Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.1.6 Mexico Candida Auris Infection Market Revenues & Volume, By Laboratory Tests, 2021- 2031F |
6.2 Mexico Candida Auris Infection Market, By Dosage |
6.2.1 Overview and Analysis |
6.2.2 Mexico Candida Auris Infection Market Revenues & Volume, By Tablet, 2021- 2031F |
6.2.3 Mexico Candida Auris Infection Market Revenues & Volume, By Injection, 2021- 2031F |
6.3 Mexico Candida Auris Infection Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Mexico Candida Auris Infection Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Mexico Candida Auris Infection Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.4 Mexico Candida Auris Infection Market Revenues & Volume, By Symptoms, 2021- 2031F |
6.3.5 Mexico Candida Auris Infection Market Revenues & Volume, By Fever, 2021- 2031F |
6.3.6 Mexico Candida Auris Infection Market Revenues & Volume, By Chills, 2021- 2031F |
6.3.7 Mexico Candida Auris Infection Market Revenues & Volume, By Sepsis, 2021- 2031F |
6.4 Mexico Candida Auris Infection Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Mexico Candida Auris Infection Market Revenues & Volume, By Clinic, 2021- 2031F |
6.4.3 Mexico Candida Auris Infection Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5 Mexico Candida Auris Infection Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Mexico Candida Auris Infection Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Mexico Candida Auris Infection Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Mexico Candida Auris Infection Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Mexico Candida Auris Infection Market Import-Export Trade Statistics |
7.1 Mexico Candida Auris Infection Market Export to Major Countries |
7.2 Mexico Candida Auris Infection Market Imports from Major Countries |
8 Mexico Candida Auris Infection Market Key Performance Indicators |
8.1 Rate of hospital-acquired Candida auris infections in Mexico |
8.2 Adoption rate of infection prevention and control measures in healthcare facilities |
8.3 Mortality rate attributed to Candida auris infections |
9 Mexico Candida Auris Infection Market - Opportunity Assessment |
9.1 Mexico Candida Auris Infection Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Mexico Candida Auris Infection Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.3 Mexico Candida Auris Infection Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Mexico Candida Auris Infection Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Mexico Candida Auris Infection Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Candida Auris Infection Market - Competitive Landscape |
10.1 Mexico Candida Auris Infection Market Revenue Share, By Companies, 2024 |
10.2 Mexico Candida Auris Infection Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here